Background illustration for clinical trials search

Paid Clinical Trials Boston

Discover 3,070 paid clinical trials in Boston, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

for
Endometriosis, Adenomyosis, Chronic Pelvic Inflammatory Disease
Location: Belmont MA
Sponsor: Staci Gruber, Ph.D.

Sex: Female

Age: 21+

Code: NCT07728695

Phase1, Phase2, Recruiting

Avelumab and M1774 in ARID1A-mutated Endometrial Cancer

for
Endometrial Cancer, ARID1A Gene Mutation,
Location: Boston MA
Sponsor: Panagiotis Konstantinopoulos, MD, PhD

Sex: Female

Age: 18+

Code: NCT06518564

Phase2, Recruiting

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

for
Metastatic Malignant Solid Neoplasm,
Location: Boston MA, Pittsburgh PA, Columbus OH, Lexington KY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05372614

Phase1, Recruiting

Development and Feasibility of CTraC-FIT

for
Functional Impairment, Functional Performance
Location: Boston MA
Sponsor: VA Office of Research and Development

Sex: All

Age: 65+

Code: NCT07132944

Recruiting

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Boston MA, Houston TX, Duarte CA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03113643

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia, CLL, Untreated, Front-line,
Location: Boston MA, New Hyde Park NY, Houston TX, La Jolla CA
Sponsor: Chronic Lymphocytic Leukemia Research Consortium

Sex: All

Age: 0+

Code: NCT00628238

Phase2, Recruiting

Scalp Cooling in MBC

for
Metastatic Breast Cancer, Chemotherapy-induced Alopecia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04986579

Phase2, Recruiting

Patient-Centered Surgical Prehabilitation

for
Bladder Cancer, Cystectomy
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70+

Code: NCT05715684

Recruiting

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

for
Ovarian Cancer, Ovarian Carcinoma, Endometrial Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT06677190

Phase2, Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Houston TX
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT06641908

Phase1, Recruiting

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

for
Colonic Neoplasms
Location: Boston MA, New York NY, Ann Arbor MI, Minneapolis MN,
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT00843375

Recruiting

The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial

for
Rectal Cancer, Colorectal Cancer, Rectal Cancer Stage II,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06565052

Recruiting

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

for
Brain Cancer, Brain Metastases, Melanoma, Lung Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT04899908

Phase2, Recruiting

Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery

for
Retroperitoneal Sarcoma
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT06812052

Phase1, Recruiting

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Providence RI, New York NY, Toronto,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT04429542

Phase1, Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: Kallyope Inc.

Sex: All

Age: 18 - 70+

Code: NCT07645924

Phase3, Recruiting

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

for
Stress, Anxiety
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 12 - 25

Code: NCT06038318

Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 18

Code: NCT06247787

Phase1, Recruiting

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: North Dartmouth MA, DuBois PA, Charlotte NC,
Sponsor: Windward Bio

Sex: All

Age: 40 - 70+

Code: NCT07646587

Phase2, Recruiting

Revumenib in Combination With 7+3 + Midostaurin in AML

for
Acute Myeloid Leukemia, AML, Adult, AML With Gene Mutations,
Location: Boston MA, New Haven CT
Sponsor: Richard Stone, MD

Sex: All

Age: 18 - 70+

Code: NCT06313437

Phase1, Recruiting

With its world-renowned healthcare network and prestigious medical research institutions, Boston is a premier destination for a wide range of clinical trials. Major centers such as Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and the Dana-Farber Cancer Institute lead groundbreaking studies across various medical fields. These institutions are at the forefront of innovation, making Boston a hub for cutting-edge clinical research.

Why choose Boston for clinical trials?

Boston stands out as a leader in healthcare and life science, and has become an important destination for participants taking part in clinical trials. With world-class medical institutions and a diverse patient population, researchers can deliver more reliable and relevant results.

The city is also home to an innovative research ecosystem, strengthened by close collaborations between hospitals, universities, and biotech companies, making it a hub for cutting-edge clinical studies.

Common conditions studied in Boston

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Boston